ALPHA Stock Overview
Operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for ALPHA from our risk checks.
Alpha IVF Group Berhad Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RM 0.35 |
| 52 Week High | RM 0.38 |
| 52 Week Low | RM 0.29 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 14.75% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALPHA | MY Healthcare | MY Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | 1.3% |
| 1Y | n/a | 23.8% | 11.2% |
Return vs Industry: Insufficient data to determine how ALPHA performed against the MY Healthcare industry.
Return vs Market: Insufficient data to determine how ALPHA performed against the MY Market.
Price Volatility
| ALPHA volatility | |
|---|---|
| ALPHA Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 3.2% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in MY Market | 10.3% |
| 10% least volatile stocks in MY Market | 2.6% |
Stable Share Price: ALPHA has not had significant price volatility in the past 3 months compared to the MY market.
Volatility Over Time: ALPHA's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 150 | Colin Lee | alphaivfgroup.com |
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia and Singapore. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation optimisation; sperm sorting; and egg freezing, embryo freezing and cryo-storage, laparoscopic surgery, hysteroscopic surgery, 4D ultrasound scanning, and artificial intelligence-enhanced embryo selection services. It also provides various diagnostics, testing and screening procedures; cryopreservation of eggs and sperms; medical consultants; fertility, gynecological, and obstetric treatment; and other women-related healthcare and medical services.
Alpha IVF Group Berhad Fundamentals Summary
| ALPHA fundamental statistics | |
|---|---|
| Market cap | RM 1.70b |
| Earnings (TTM) | RM 54.65m |
| Revenue (TTM) | RM 170.51m |
31.1x
P/E Ratio10.0x
P/S RatioIs ALPHA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALPHA income statement (TTM) | |
|---|---|
| Revenue | RM 170.51m |
| Cost of Revenue | RM 70.35m |
| Gross Profit | RM 100.16m |
| Other Expenses | RM 45.52m |
| Earnings | RM 54.65m |
Last Reported Earnings
Aug 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.011 |
| Gross Margin | 58.74% |
| Net Profit Margin | 32.05% |
| Debt/Equity Ratio | 0% |
How did ALPHA perform over the long term?
See historical performance and comparison